Cargando…

Cognitive Processes Underlying Verbal Fluency in Multiple Sclerosis

Background: Verbal fluency (VF) has been associated with several cognitive functions, but the cognitive processes underlying verbal fluency deficits in Multiple Sclerosis (MS) are controversial. Further knowledge about VF could be useful in clinical practice, because these tasks are brief, applicabl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delgado-Álvarez, Alfonso, Matias-Guiu, Jordi A., Delgado-Alonso, Cristina, Hernández-Lorenzo, Laura, Cortés-Martínez, Ana, Vidorreta, Lucía, Montero-Escribano, Paloma, Pytel, Vanesa, Matias-Guiu, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859643/ https://www.ncbi.nlm.nih.gov/pubmed/33551984 http://dx.doi.org/10.3389/fneur.2020.629183

Ejemplares similares

Memory Impairment in Relapsing-Remitting Multiple Sclerosis Using a Challenging Semantic Interference Task
por: Matias-Guiu, Jordi A., et al.
Publicado: (2020)

Identification of Cortical and Subcortical Correlates of Cognitive Performance in Multiple Sclerosis Using Voxel-Based Morphometry
por: Matías-Guiu, Jordi A., et al.
Publicado: (2018)

Potential COVID-19 infection in patients with severe multiple sclerosis treated with alemtuzumab
por: Matías-Guiu, Jorge, et al.
Publicado: (2020)

Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
por: Montero-Escribano, Paloma, et al.
Publicado: (2020)

Variants of genes encoding TNF receptors and ligands and proteins regulating TNF activation in familial multiple sclerosis
por: Torre‐Fuentes, Laura, et al.
Publicado: (2020)

Particles Containing Cells as a Strategy to Promote Remyelination in Patients With Multiple Sclerosis
por: Matías-Guiu, Jorge, et al.
Publicado: (2020)

Exonic variants of genes related to the vitamin D signaling pathway in the families of familial multiple sclerosis using whole‐exome next generation sequencing
por: Pytel, Vanesa, et al.
Publicado: (2019)

Structural MRI correlates of PASAT performance in multiple sclerosis
por: Matias-Guiu, Jordi A., et al.
Publicado: (2018)

Functional Components of Cognitive Impairment in Multiple Sclerosis: A Cross-Sectional Investigation
por: Matias-Guiu, Jordi A., et al.
Publicado: (2017)

Application of Machine Learning to Electroencephalography for the Diagnosis of Primary Progressive Aphasia: A Pilot Study
por: Moral-Rubio, Carlos, et al.
Publicado: (2021)

Sera from Patients with NMOSD Reduce the Differentiation Capacity of Precursor Cells in the Central Nervous System
por: Gómez-Pinedo, Ulises, et al.
Publicado: (2021)

Familial multiple sclerosis and association with other autoimmune diseases
por: Pytel, Vanesa, et al.
Publicado: (2017)

Notch Signalling in the Hippocampus of Patients With Motor Neuron Disease
por: Gómez-Pinedo, Ulises, et al.
Publicado: (2019)

GA-MADRID: design and validation of a machine learning tool for the diagnosis of Alzheimer’s disease and frontotemporal dementia using genetic algorithms
por: García-Gutierrez, Fernando, et al.
Publicado: (2022)

Editorial: COVID-19 in CNS and PNS: Basic and Clinical Focus on the Mechanisms of Infection and New Tools for the Therapeutic Approach
por: Matias-Guiu, Jorge, et al.
Publicado: (2022)

Vitamin D increases remyelination by promoting oligodendrocyte lineage differentiation
por: Gomez‐Pinedo, Ulises, et al.
Publicado: (2019)

Fatigue and Cognitive Dysfunction Are Associated with Occupational Status in Post-COVID Syndrome
por: Delgado-Alonso, Cristina, et al.
Publicado: (2022)

Neural basis of visuospatial tests in behavioral variant frontotemporal dementia
por: Delgado-Álvarez, Alfonso, et al.
Publicado: (2022)

Genetic Algorithms for Optimized Diagnosis of Alzheimer’s Disease and Frontotemporal Dementia Using Fluorodeoxyglucose Positron Emission Tomography Imaging
por: Díaz-Álvarez, Josefa, et al.
Publicado: (2022)

Transcranial direct current stimulation for post-COVID fatigue: a randomized, double-blind, controlled pilot study
por: Oliver-Mas, Silvia, et al.
Publicado: (2023)

Striatal volume is related to phonemic verbal fluency but not to semantic or alternating verbal fluency in early Parkinson’s disease
por: Ellfolk, Ulla, et al.
Publicado: (2013)

Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study
por: Delgado-Alonso, Cristina, et al.
Publicado: (2022)

Clustering Analysis of FDG-PET Imaging in Primary Progressive Aphasia
por: Matias-Guiu, Jordi A., et al.
Publicado: (2018)

Examining Association of Personality Characteristics and Neuropsychiatric Symptoms in Post-COVID Syndrome
por: Delgado-Alonso, Cristina, et al.
Publicado: (2022)

Validation of the cross-cultural dementia screening test in Alzheimer’s disease and Parkinson’s disease
por: Delgado-Álvarez, Alfonso, et al.
Publicado: (2023)

Validation of the European Cross-Cultural Neuropsychological Test Battery (CNTB) for the assessment of mild cognitive impairment due to Alzheimer's disease and Parkinson's disease
por: Delgado-Álvarez, Alfonso, et al.
Publicado: (2023)

Editorial: The Use of Biomaterials With Stem and Precursor Cells in Diseases of the Central Nervous System; A Step to Clinical Trials
por: Ramos-Zúñiga, Rodrigo, et al.
Publicado: (2021)

In Vitro Effects of Methylprednisolone over Oligodendroglial Cells: Foresight to Future Cell Therapies
por: Gómez-Pinedo, Ulises, et al.
Publicado: (2023)

Quantitative EEG and Verbal Fluency in DBS Patients: Comparison of Stimulator-On and -Off Conditions
por: Hatz, Florian, et al.
Publicado: (2019)

Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET Imaging
por: Matías-Guiu, Jordi A., et al.
Publicado: (2016)

FDG-PET-based neural correlates of Addenbrooke’s cognitive examination III scores in Alzheimer’s disease and frontotemporal degeneration
por: Cabrera-Martín, María Nieves, et al.
Publicado: (2023)

Predominance of visuoconstructive impairment after mild COVID-19?
por: Díez-Cirarda, María, et al.
Publicado: (2022)

Should we expect neurological symptoms in the SARS-CoV-2 epidemic?()
por: Matías-Guiu, J., et al.
Publicado: (2020)

¿Es esperable que haya cuadros neurológicos por la pandemia por SARS-CoV-2?
por: Matías-Guiu, J., et al.
Publicado: (2020)

Intranasal Administration of Undifferentiated Oligodendrocyte Lineage Cells as a Potential Approach to Deliver Oligodendrocyte Precursor Cells into Brain
por: Gómez-Pinedo, Ulises, et al.
Publicado: (2021)

Modelos experimentales de desmielinización-remielinización
por: Torre-Fuentes, L., et al.
Publicado: (2020)

Experimental models of demyelination and remyelination()
por: Torre-Fuentes, L., et al.
Publicado: (2020)

Amyloid PET imaging in multiple sclerosis: an (18)F-florbetaben study
por: Matías-Guiu, Jordi A., et al.
Publicado: (2015)

Editorial: Consequences of the COVID-19 Pandemic on Care for Neurological Conditions
por: Matias-Guiu, Jordi A., et al.
Publicado: (2021)

“Brain Fog” by COVID-19 or Alzheimer’s Disease? A Case Report
por: Matias-Guiu, Jordi A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tm9m8m6j1v416k7ohd0rdln8s1